01 24Gowling WLG (Canada) LLP
01 32524047
02 32747437
03 32747992
04 32823616
05 32900844
06 32942236
07 32943598
08 33105857
01 24SIPONIMOD
01 24TABLET
01 32024-05-19
02 32029-12-16
03 62029-12-21
04 32032-01-05
05 32033-04-19
06 62035-04-08
Patent Expiration Date : 2024-05-19
Date Granted : 2013-06-18
Brand Name : MAYZENT
Patent Number : 2524047
Filing Date : 2004-05-19
Strength per Unit : 0.25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-05-19
Date Granted : 2013-06-18
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-16
Date Granted : 2018-08-21
Brand Name : MAYZENT
Patent Number : 2747437
Filing Date : 2009-12-16
Strength per Unit : 0.25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-12-16
Date Granted : 2018-08-21
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-21
Date Granted : 2017-11-07
Brand Name : MAYZENT
Patent Number : 2747992
Filing Date : 2009-12-21
Strength per Unit : 0.25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-12-21
Date Granted : 2017-11-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-01-05
Date Granted : 2019-01-29
Brand Name : MAYZENT
Patent Number : 2823616
Filing Date : 2012-01-05
Strength per Unit : 0.25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-01-05
Date Granted : 2019-01-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-04-19
Date Granted : 2022-05-03
Brand Name : MAYZENT
Patent Number : 2900844
Filing Date : 2013-04-19
Strength per Unit : 0.25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-04-19
Date Granted : 2022-05-03
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-21
Date Granted : 2023-08-01
Brand Name : MAYZENT
Patent Number : 3105857
Filing Date : 2009-12-21
Strength per Unit : 0.25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-12-21
Date Granted : 2023-08-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-04-08
Date Granted : 2023-03-07
Brand Name : MAYZENT
Patent Number : 2943598
Filing Date : 2015-04-08
Strength per Unit : 0.25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2035-04-08
Date Granted : 2023-03-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-04-08
Date Granted : 2023-08-29
Brand Name : MAYZENT
Patent Number : 2942236
Filing Date : 2015-04-08
Strength per Unit : 0.25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2035-04-08
Date Granted : 2023-08-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-05-19
Date Granted : 2013-06-18
Brand Name : MAYZENT
Patent Number : 2524047
Filing Date : 2004-05-19
Strength per Unit : 2 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-05-19
Date Granted : 2013-06-18
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-16
Date Granted : 2018-08-21
Brand Name : MAYZENT
Patent Number : 2747437
Filing Date : 2009-12-16
Strength per Unit : 2 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-12-16
Date Granted : 2018-08-21
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
